RPL13A as a reference gene for normalizing mRNA transcription of ovarian cancer cells with paclitaxel and 10-hydroxycamptothecin treatments

Bian,Zehua; Yu,Yang; Quan,Chao; Guan,Rongwei; Jin,Yan; Wu,Jie; Xu,Lidan; Chen,Feng; Bai,Jing; Sun,Wenjing; Fu,Songbin

doi:10.3892/mmr.2014.3108

RPL13A as a reference gene for normalizing mRNA transcription of ovarian cancer cells with paclitaxel and 10-hydroxycamptothecin treatments

Authors:
- Zehua Bian
- Yang Yu
- Chao Quan
- Rongwei Guan
- Yan Jin
- Jie Wu
- Lidan Xu
- Feng Chen
- Jing Bai
- Wenjing Sun
- Songbin Fu
View Affiliations

Affiliations: Laboratory of Medical Genetics, Harbin Medical University, Harbin, Heilongjiang 150081, P.R. China
Published online on: December 17, 2014 https://doi.org/10.3892/mmr.2014.3108
Pages: 3188-3194

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Gene transcription analysis is important in cancer research, and reverse transcription‑quantitative polymerase chain reaction (RT‑qPCR) has been demonstrated to be an effective method to evaluate gene transcription in cancer. RT‑qPCR requires an internal reference gene with a consistent level of mRNA transcription across various experimental conditions. However, it has been suggested that different treatments, including anticancer therapy, may influence the transcriptional stability of internal reference genes. Paclitaxel (PTX) and 10‑hydroxycamptothecin (HCPT) are widely used to treat various types of cancer, and a suitable internal reference gene is required in order to analyze the transcription profiles of the cells following treatment. In the current study, the transcriptional stability of 30 candidate reference genes was investigated in cancer cells following treatment with PTX and HCPT. The two ovarian cancer cell lines, UACC‑1598 and SKOV3, were treated with PTX and HCPT for 24 and 48 h, and the transcriptional levels of the candidate reference genes were subsequently evaluated by RT‑qPCR analysis. The transcriptional stability of the selected genes was then analyzed using qbase+ and NormFinder software. A total of 9 genes were demonstrated to exhibit high transcriptional stability and one of these genes, ribosomal protein L13a (RPL13A), was identified to exhibit high transcriptional stability in every group. The current study identified various reference genes suitable under different circumstances, while RPL13A was indicated to be the most suitable reference gene for analyzing the transcription profile of ovarian cancer cells following treatment with PTX and HCPT.

View Figures

View References

1	Pal S, Gupta R and Davuluri RV: Alternative transcription and alternative splicing in cancer. Pharmacol Ther. 136:283–294. 2012. View Article : Google Scholar : PubMed/NCBI
2	Richardson A and Kaye SB: Drug resistance in ovarian cancer: the emerging importance of gene transcription and spatio-temporal regulation resistance. Drug Resist Updat. 8:311–321. 2005. View Article : Google Scholar : PubMed/NCBI
3	Lin Y, Zhang C, Lan H, Gao S, et al: Validation of potential reference genes for qPCR in maize across abiotic stresses, hormone treatments, and tissue types. PLoS One. 9:e954452014. View Article : Google Scholar : PubMed/NCBI
4	Schmittgen TD and Zakrajsek BA: Effect of experimental treatment on housekeeping gene expression: validation by real-time, quantitative RT-PCR. J Biochem Biophys Methods. 46:69–81. 2000. View Article : Google Scholar : PubMed/NCBI
5	Caradec J, Sirab N, Keumeugni C, et al: ‘Desperate house genes’: the dramatic example of hypoxia. Br J Cancer. 102:1037–1043. 2010. View Article : Google Scholar : PubMed/NCBI
6	Dheda K, Huggett JF, Chang JS, et al: The implications of using an inappropriate reference gene for real-time reverse transcription PCR data normalization. Anal Biochem. 344:141–143. 2005. View Article : Google Scholar : PubMed/NCBI
7	Montana M, Ducros C, Verhaeghe P, Terme T, Vanelle P and Rathelot P: Albumin-bound paclitaxel: the benefit of this new formulation in the treatment of various cancers. J Chemother. 23:59–66. 2011. View Article : Google Scholar : PubMed/NCBI
8	Wang N, Zhang H, Yao Q, Wang Y, Dai S and Yang X: TGFBI promoter hypermethylation correlating with paclitaxel chemoresistance in ovarian cancer. J Exp Clin Cancer Res. 31:62012. View Article : Google Scholar : PubMed/NCBI
9	Socinski MA, Okamoto I, Hon JK, et al: Safety and efficacy analysis by histology of weekly nab-paclitaxel in combination with carboplatin as first-line therapy in patients with advanced non-small-cell lung cancer. Ann Oncol. 24:2390–2396. 2013. View Article : Google Scholar : PubMed/NCBI
10	Amos LA and Löwe J: How Taxol stabilises microtubule structure. Chem Biol. 6:R65–R69. 1999. View Article : Google Scholar : PubMed/NCBI
11	Ferlini C, Cicchillitti L, Raspaglio G, et al: Paclitaxel directly binds to Bcl-2 and functionally mimics activity of Nur77. Cancer Res. 69:6906–6914. 2009. View Article : Google Scholar : PubMed/NCBI
12	Ping YH, Lee HC, Lee JY, et al: Anticancer effects of low-dose 10-hydroxycamptothecin in human colon cancer. Oncol Rep. 15:1273–1279. 2006.PubMed/NCBI
13	Zhang XW, Qing C and Xu B: Apoptosis induction and cell cycle perturbation in human hepatoma hep G2 cells by 10-hydroxycamptothecin. Anticancer Drugs. 10:569–576. 1999. View Article : Google Scholar
14	Lesueur-Ginot L, Demarquay D, Kiss R, et al: Homocamptothecin, an E-ring modified camptothecin with enhanced lactone stability, retains topoisomerase I-targeted activity and antitumor properties. Cancer Res. 59:2939–2943. 1999.PubMed/NCBI
15	Shoji T, Takatori E, Kaido Y, et al: A phase I study of irinotecan and pegylated liposomal doxorubicin in recurrent ovarian cancer (Tohoku Gynecologic Cancer Unit 104 study). Cancer Chemother Pharmacol. 73:895–901. 2014. View Article : Google Scholar : PubMed/NCBI
16	Rino Y, Yukawa N, Sato T, et al: Phase II study on the combination of irinotecan plus cisplatin as a second-line therapy in patients with advanced or recurrent gastric cancer. Mol Clin Oncol. 1:749–752. 2013.
17	Hertzberg RP, Caranfa MJ and Hecht SM: On the mechanism of topoisomerase I inhibition by camptothecin: evidence for binding to an enzyme-DNA complex. Biochem. 28:4629–4638. 1989. View Article : Google Scholar
18	Fukada M: Action of camptothecin and its derivatives on deoxyribonucleic acid. Biochem Pharmacol. 34:1225–1230. 1985. View Article : Google Scholar : PubMed/NCBI
19	Cicinnati VR, Shen Q, Sotiropoulos GC, Radtke A, Gerken G and Beckebaum S: Validation of putative reference genes for gene expression studies in human hepatocellular carcinoma using real-time quantitative RT-PCR. BMC Cancer. 8:3502008. View Article : Google Scholar : PubMed/NCBI
20	Gresner P, Gromadzinska J and Wasowicz W: Reference genes for gene expression studies on non-small cell lung cancer. Acta Biochim Pol. 56:307–316. 2009.PubMed/NCBI
21	Valceckiene V, Kontenyte R, Jakubauskas A and Griskevicius L: Selection of reference genes for quantitative polymerase chain reaction studies in purified B cells from B cell chronic lymphocytic leukaemia patients. Br J Haematol. 151:232–238. 2010. View Article : Google Scholar : PubMed/NCBI
22	Ferreira E and Cronjé MJ: Selection of suitable reference genes for quantitative real-time PCR in apoptosis-induced MCF-7 breast cancer cells. Mol Biotechnol. 50:121–128. 2012. View Article : Google Scholar
23	Andersen CL, Jensen JL and Ørntoft TF: Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res. 64:5245–5250. 2004. View Article : Google Scholar : PubMed/NCBI
24	Ohl F, Jung M, Xu C, et al: Gene expression studies in prostate cancer tissue: which reference gene should be selected for normalization? J Mol Med (Berl). 83:1014–1024. 2005. View Article : Google Scholar
25	Fu J, Bian L, Zhao L, et al: Identification of genes for normalization of quantitative real-time PCR data in ovarian tissues. Acta Biochim Biophys Sin (Shanghai). 42:568–574. 2010. View Article : Google Scholar
26	Li YL, Ye F, Hu Y, Lu WG and Xie X: Identification of suitable reference genes for gene expression studies of human serous ovarian cancer by real-time polymerase chain reaction. Anal Biochem. 394:110–116. 2009. View Article : Google Scholar : PubMed/NCBI
27	Shah KN and Faridi JS: Estrogen, tamoxifen, and Akt modulate expression of putative housekeeping genes in breast cancer cells. J Steroid Biochem Mol Biol. 125:219–225. 2011. View Article : Google Scholar : PubMed/NCBI